Source link : https://www.newshealth.biz/health-news/fda-expands-pembrolizumab-approval-for-endometrial-cancer/
The US Food and Drug Administration (FDA) has expanded the indication for pembrolizumab (Keytruda, Merck) to include the use of the targeted immunotherapy agent plus chemotherapy followed by single-agent pembrolizumab in adults with primary advanced or recurrent endometrial cancer. Approval in this setting was granted following priority review and was based on efficacy demonstrated in […]
Author : News Health
Publish date : 2024-06-18 07:03:42
Copyright for syndicated content belongs to the linked Source.
Categories